Showing results (71-80 of 689) with videos related to

Sort By:
Pageof 69
Current Opinion in Clinical Nutrition and Metabolic Care|October 26, 2012
Physiology of the ageing gutChristopher K Rayner, Michael Horowitz
Nutrients|October 23, 2021
Appetite and Satiety Control-Contribution of Gut MechanismsChristine Feinle-Bisset, Michael Horowitz
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|July 3, 2020
A Prospective, Randomized Trial Testing Different Regimens of Carbohydrate Administration to Prevent Major Reduction in Plasma Glucose Follwing a Standardized Bout of Moderate Physical Activity in Patients with Type 1 DiabetesHanna Frenzke, Annette Varnhorn, Heike Schulze, et al.
Diabetes, Obesity & Metabolism|July 26, 2021
The evolving story of incretins (GIP and GLP-1) in metabolic and cardiovascular disease: A pathophysiological updateMichael A Nauck, Daniel R Quast, Jakob Wefers, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|December 17, 2021
Hypothesis: Bolus jejunal feeding via an enteral feeding tube simulates key features of gastric bypass to initiate similar clinical benefitsElizabeth Ogden Beale, Michael Horowitz
American Journal of Physiology. Endocrinology and Metabolism|July 5, 2007
Reduction of hepatic insulin clearance after oral glucose ingestion is not mediated by glucagon-like peptide 1 or gastric inhibitory polypeptide in humansJuris J Meier, Jens J Holst, Wolfgang E Schmidt, et al.
Diabetes, Obesity & Metabolism|January 7, 2017
Basal rate tests (24-hour fasts) performed in type-1 diabetic subjects with either absolute fasting or snacks containing negligible carbohydrate amounts result in similar glucose profiles: A randomized controlled prospective trialMaike Haase, Melanie Kahle, Martin Janert, et al.
Diabetes Care|January 19, 2024
A Methodological Framework for Meta-analysis and Clinical Interpretation of Subgroup Data: The Case of Major Adverse Cardiovascular Events With GLP-1 Receptor Agonists and SGLT2 Inhibitors in Type 2 DiabetesThomas Karagiannis, Apostolos Tsapas, Eleni Bekiari, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|July 20, 2023
Prospective External Validation of an Algorithm Predicting Hourly Basal Insulin Infusion Rates from Characteristics of Patients with Type 1 Diabetes Treated with Insulin PumpsJana S Schmelzer, Melanie Kahle-Stephan, Juris J Meier, et al.
Nutrients|January 8, 2023
Effects of Initial Combinations of Gemigliptin Plus Metformin Compared with Glimepiride Plus Metformin on Gut Microbiota and Glucose Regulation in Obese Patients with Type 2 Diabetes: The INTESTINE StudySoo Lim, Minji Sohn, Jose C Florez, et al.
Pageof 69